3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
13
Spondylitis, Ankylosing
4
Psoriasis
4
Colitis, Ulcerative
3
Uveal Melanoma
1
Spondylarthritis
1
Recurrence
1
Plaque Psoriasis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammatory Bowel Diseases
1
Inflammation
1
Hidradenitis Suppurativa
1
Healthy
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Crohn Disease
1
Arthritis, Psoriatic
1
Arthritis
1
Acne Vulgaris
1
Abscess
1
Interventions
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hidradenitis Suppurativa
×
Adalimumab
×
Clear all
NCT01635764
2018-01-24
PIONEER (OLE)
AbbVie
Phase 3
Completed
508 enrolled
9 charts